sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Tue Mar 17
Jim Cramer on Regeneron (REGN): “I Think The Stock’s Breaking Out Here”
4d
Y
Earnings Preview: What to Expect From Royal Caribbean Cruises' Report
4d
Y
Jim Cramer on D-Wave (QBTS): “Maybe the Science Project Works Out, But It Is More of a Science Project”
4d
Y
Jim Cramer Bearish on Newsmax (NMAX) Because “They’re Losing Money”
4d
Y
Jim Cramer on Qnity: “It’s Probably the Most Undervalued of the Data Center Stocks Right Now”
4d
Y
Should You Buy the Dip on This Soaring Energy Stock?
4d
Y
Jim Cramer Says “I Think at 5.25% Yield, I Want to Own Kimberly-Clark (KMB)”
4d
Y
Jim Cramer on The Vita Coco Company (COCO): “I Think This Could Be a Nice Buying Opportunity”
4d
Y
Jim Cramer on Levi Strauss (LEVI): “This Stock Could Have Lots of Upside Ahead of It”
4d
Y
Jim Cramer on Reddit (RDDT): “The Stock Is Suffering, the Company’s Not”
4d
Y
Jim Cramer on Abercrombie & Fitch (ANB): “I Think the Bounce Back Is Very for Real”
4d
Y
Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights
4d
Y
Genius Sports (GENI) Hits 52-Week Low Following 50% Year-to-Date Decline
4d
Y
Analysts Bullish on CytomX Therapeutics (CTMX) As CTMX Prices $250 Million Offering
4d
Y
Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?
4d
Y
Repay Holdings (RPAY) Scales Up in Bill Payments and Customer Interactions; Analysts See 170%+ Upside
4d
Y
Analysts Remain Bullish on Gossamer Bio (GOSS) Despite Phase 3 Setback
4d
Y
Does Exagen (XGN)’s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode?
4d
Y
Neumora Therapeutics (NMRA) Is Among the Best Penny Stocks Set to Explode
4d
Y
UBS Cautious on Fermi (FRMI) Outlook As It Awaits First Tenant Lease
4d
Y
ARKO (APC) Is Among the Best Buy-Rated All-Time Low Stocks to Buy – Here Is Why
4d
Y
Fermi (FRMI) Secures Up to $156.25M in Committed Financing
4d
Y
Keefe Bruyette Lowers Its Price Target on KKR Real Estate Finance Trust (KREF)
4d
Y
Herc Holdings Inc. (HRI): Mario Gabelli Makes Minor Adjustment to Stake
4d
Y
MapLight Therapeutics (MPLT): The Best Healthcare Stock Insiders Are Buying
4d
Y
Should You Buy the Vanguard Information Technology ETF During the Nasdaq Correction? History Offers a Clear Answer
4d
Y
American Express Company (AXP): Mario Gabelli Likes This Payments Company
4d
Y
Wells Fargo Maintains Overweight Rating on Phreesia (PHR)
4d
Y
Morgan Stanley Raises its Price Target on Sonida Senior Living (SNDA) to $31
4d
Y
Veradermics (MANE) Reports Q4 Net Loss of $21.8M
4d
Y
Vinod Khosla Is Betting On This 'Exciting Company' Building Fast Aircraft As It Chases $1 Billion Valuation
4d
Y
Madison Square Garden Sports (MSGS): Mario Gabelli Is Bullish on This Stock
4d
Y
The Great Rotation: Buy This Sector Before It Comes Back in Style
4d
Y
Textron Inc. (TXT): Mario Gabelli Has a Long-Term Bet on This Stock
4d
Y
AMETEK Inc. (AME): Mario Gabelli Is Betting Big on This Stock
4d
Y
Sony Group Corporation (SONY): Mario Gabelli Remains Bullish on This Stock
4d
Y
The Bank of New York Mellon Corporation (BK): Mario Gabelli Admires This Banking Stock
4d
Y
Truist Maintains Buy Rating on SmartStop Self Storage REIT (SMA)
4d
Y
StubHub Holdings (STUB) Partners with vivenu to Expand Ticket Distribution
4d
Y
EquipmentShare (EQPT): The Best Buy-Rated All-Time Low Stock to Buy
4d
Y
Piper Sandler Maintains Overweight Rating on Blue Owl Capital (OWL)
4d
Y
Erste Group Downgrades Toyota Motor (TM) to Hold
4d
Y
BofA Lowers its Price Target on Pfizer (PFE) to $26 from $27
4d
Y
Here is why Devon Energy (DVN) is Among the Best Cheap Large Cap Stocks to Buy Now
4d
Y
Wells Fargo Maintains Overweight Rating on Synchrony (SYF)
4d
Y
UBS Raises its Price Target on MetLife (MET) to $102
4d
Y
Cantor Fitzgerald Maintains Overweight Rating on Hartford Insurance (HIG)
4d
Y
BofA Raises its Price Target on Teva Pharmaceutical (TEVA) to $42
4d
Y
Delta Air Lines (DAL): The Best Cheap Large Cap Stock to Buy Now
4d
Y
Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05)
4d
Y
More →